Download presentation
Presentation is loading. Please wait.
Published byFrederick Berry Modified over 8 years ago
1
Evidence-Based Target Pressures Paul Palmberg, MD, PhD Bascom Palmer Eye Institute University of Miami School of Medicine How to Achieve Low Target Pressures Safely with MMC or 5-FU
2
Advanced Glaucoma Intervention Study All < 18 mmHg 75%-99% < 18 50%-74% < 18 < 50% < 18 The AGIS Investigators. Am J Ophthalmol. 2000;130:429-440.
3
Can MMC or 5-FU give us the low IOP we want without too many complications? nWe could reduce post-op healing nWhat would be the cost? nHow could we get a discount?
4
How to use MMC or 5-FU Safely nThe use of Mitomycin C or 5-Fluorouracil never causes hypotony. nBUT, the use of MMC or 5-FU will preserve any hypotony you create! nAntimetabolites allow one to use a new strategy: 1) set the IOP by adjusting the scleral resistance 2) use antimetabolites to prevent the formation of additional resistance in the conjunctiva-Tenons
5
Highlights of Ophthalmology 1993
10
Primary Filtering Surgery with 5-FU or Mitomycin: Intraocular Pressure Control and Visual Field Data mm Hg # (IOP) MD PSD # fields Pre-OP26.1 212 -14.3 7.58 181 1 Year10.7183-13.67.59 117 2 Years10.8161-12.47.67 96 3 Years10.8143-13.38.18 92 4 Years10.5125-13.68.05 71 5 Years11.8123-11.97.68 65 6 Years10.6 99-13.08.70 47 7 Years11.0 81-12.69.34 42 8 Years11.0 63-12.78.79 22 9 Years10.4 46-10.77.42 19 10 Years11.0 30-12.18.71 13 Ishida K, E Escalona, J Schiffman, Palmberg P, ARVO 2003 Technique: Suner, et al, Ophthalmology 1997:104:207-214.
11
Mean MD over time Mean change of MD over time MD(dB) ⊿ MD(dB) -6 -4 -2 0 2 4 6 ⊿ 1yMD ⊿ 2yMD ⊿ 3yMD ⊿ 4yMD ⊿ 5yMD ⊿ 6yMD ⊿ 7yMD ⊿ 8yMD ⊿ 9yMD ⊿ 10yMD Mean±S.E. N=181 116 96 91 72 65 47 42 22 29 13 N=109 86 85 68 59 44 35 21 23 9 > 0 = deterioration There was no statistical difference between baseline and each year’s value ( Wilcoxon signed ranks test ).
12
Improve tissue function? Hypothesis Occleston et al Invest Ophthalmol Vis Sci 1997, Daniels et al 1999 Exp Eye Res Growth arrested cells Release stimulatory factors Stimulate normal fibroblasts Ring of scar tissue “ring of steel” + Anterior drainage jet Thinned area
13
System to prevent complications of filtration surgery (trabeculectomy) Infusion Khaw
14
Results Results DiscomfortDiscomfort LeakageLeakage HypotonyHypotony BlebitisBlebitis EndophthalmitisEndophthalmitis
15
Results Results Bleb related problems inc leaks / blebitis / endoph 0% 20% 0% 20% After change Fornix based Large Area MMC 0.5 mg/ml Ophthalmology 2003 in press Before Change Limbus based Small Area MMC 0.4 mg/ml
16
IOP vs 5 Yr Risk of Progression
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.